According to Wu, Two Seas Capital, the largest shareholder of Core Scientific, announced that it will vote against the all-stock sale to CoreWeave, stating that the transaction is undervalued and has significant structural flaws. Previously, CoreWeave announced on July 7 that it intended to acquire Core Scientific in an all-stock deal valued at $9 billion.

CORE-1.82%
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate app
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)